chartexchange

BOLT
Bolt Biotherapeutics, Inc. Common Stock
stockNASDAQ

Market OpenOct 23, 2026 1:16:28 PM EDT
6.86USD+63.723%(+2.67)11,479,388
6.8500Bid6.9100Ask0.0600Spread
Loading…
Loading…
Healthcare
Biotechnology
HQ
Redwood City, CA, USA
Previous Close
$4.19
Beta
0.81
52-Week High
$7.20 2026-01-16
52-Week Low
$3.10 2026-09-18
SMA 50
$3.75
SMA 200
$4.49
Avg. Vol 10D
27,895
Avg. Vol 30D
33,803
Avg. Vol 90D
27,208
Relative Vol
339.17
1.62M
4.7300%
Nov 11, 2026 (19d)
Jun 9, 2025 · 1-for-20 (reverse)
BOLT Profile

bolt biotherapeutics is a start-up with compelling technology from dr. engleman's lab at stanford university, which demonstrated complete cures in numerous cancer models. the company is backed by strong life sciences investors and is early in its growth curve, seeking bright, highly motivated individuals that will be the company's future leaders to help it further develop and bring to patients novel and curative biotherapies.

BOLT Performance
PeriodPriceDateChangeBeta
1W4.002026-10-16+71.65%-0.491
1M3.652026-09-23+88.11%2.989
3M3.812026-07-23+80.21%1.208
6M4.772026-04-23+43.94%0.690
1Y5.762025-10-23+19.20%0.811
2Y13.002024-10-23-47.18%—
5Y259.802021-10-22-97.36%0.848
BOLT Stock Summary

Bolt Biotherapeutics, Inc. Common Stock (NASDAQ:BOLT) stock price today is $6.87, and today's volume is 11,465,095. BOLT is up 63.864% today. The 30 day average volume is 33,803. BOLT market cap is $13.23M with 1.93M shares outstanding.